Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
STT3A-CDG is a form of congenital disorders of N-linked glycosylation characterized by developmental delay, intellectual disability, failure to thrive, hypotonia and seizures. STT3A-CDG is caused by mutations in the gene STT3A (11q23.3).
Features include always present findings: Microcephaly, Feeding difficulties, Failure to thrive, and Shrinkage of the cerebellum (cerebellar atrophy) and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 3 | Seizure, Global developmental delay, Intellectual disability |
STT3A function has not been fully characterized.
STT3A-congenital disorder of glycosylation has been associated with mutations in the STT3A gene on chromosome 11.
Genetic testing for STT3A is available. Testing is considered supportive for diagnosis.
Biomarker and diagnostic research for STT3A-congenital disorder of glycosylation has been reported in the published literature.
Phenotype severity distribution: 9 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for STT3A-congenital disorder of glycosylation.
207 publications have been identified in PubMed for STT3A-congenital disorder of glycosylation. Kisho has analyzed 63 by research type. Research spans Review / Meta-Analysis (43%), Basic Science / Preclinical (40%), and Epidemiology / Natural History (8%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 27 | 43% |
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 4:39 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about STT3A-congenital disorder of glycosylation
2 |
Shrinkage of the cerebellum (cerebellar atrophy), Low muscle tone (hypotonia) |
Head and neck | 1 | Microcephaly |
Digestive system | 1 | Feeding difficulties |
Growth and development | 1 | Failure to thrive |
Laboratory research |
25 |
40% |
Disease patterns and progression | 5 | 8% |
Testing and diagnosis research | 2 | 3% |
Patient case studies | 2 | 3% |
Other research | 1 | 2% |
New treatment approaches | 1 | 2% |
Yamsek M (2026). [PMID: 41261126](https://pubmed.ncbi.nlm.nih.gov/41261126/). *Nature*. [Basic Science / Preclinical]
Al-Shahrani H (2026). [PMID: 41897354](https://pubmed.ncbi.nlm.nih.gov/41897354/). *Biomolecules*. [Case Report / Case Series]
Ng BG (2026). [PMID: 41935956](https://pubmed.ncbi.nlm.nih.gov/41935956/). *HGG Adv*. [Basic Science / Preclinical]
Yi L (2026). [PMID: 41264770](https://pubmed.ncbi.nlm.nih.gov/41264770/). *Protein Cell*. [Review / Meta-Analysis]
Wang S (2025). [PMID: 40166934](https://pubmed.ncbi.nlm.nih.gov/40166934/). *J Clin Invest*. [Basic Science / Preclinical]
Zhou Q (2025). [PMID: 40660266](https://pubmed.ncbi.nlm.nih.gov/40660266/). *Cardiovasc Diabetol*. [Review / Meta-Analysis]
Du X (2025). [PMID: 39991767](https://pubmed.ncbi.nlm.nih.gov/39991767/). *Int J Med Sci*. [Review / Meta-Analysis]
Alharbi H (2025). [PMID: 39923392](https://pubmed.ncbi.nlm.nih.gov/39923392/). *Mol Genet Metab*. [Epidemiology / Natural History]
Prakash S (2025). [PMID: 40153534](https://pubmed.ncbi.nlm.nih.gov/40153534/). *J Clin Invest*. [Basic Science / Preclinical]
Shi SM (2025). [PMID: 40011765](https://pubmed.ncbi.nlm.nih.gov/40011765/). *Nature*. [Basic Science / Preclinical]